
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Royalty Pharma (NASDAQ:RPRX) through any online brokerage.
Other companies in Royalty Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Royalty Pharma has a consensus price target of $53.78.
The stock price for Royalty Pharma (NASDAQ: RPRX) is $61.56 last updated August 31, 2026 at 6:48 PM EDT.
There are no upcoming dividends for Royalty Pharma.
Royalty Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Royalty Pharma.
Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.